In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 percent of their body weight.
Več na: https://www.wired.com/story/eli-lillys-obesity-pill-shows-promising-weight-loss-in-new-results/